Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

How technology can help you take your drugs faster to market?

42 views

Published on

The First Industrial Revolution used water and steam power to mechanize production. The Second used electric power to create mass production. The Third used electronics and information technology to automate production. Now a Fourth Industrial Revolution is building on the Third, the digital revolution that has been occurring since the middle of the last century. It is characterized by a fusion of technologies that is blurring the lines between the physical, digital, and biological spheres. Learn how the 4th revolution is changing the way clinical trials are conducted

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this

How technology can help you take your drugs faster to market?

  1. 1. How technology can help you take your drugs faster to market
  2. 2. The 4th revolution is here! It’s a connected world Artificial Intelligence Robotics Internet Of Things 3D Printing Autonomous Vehicles Quantum Computing By 2025, 5% of consumer products will be printed in 3D In 10 years, AI machine will chair the board meeting 10% of people wearing clothes will be connected to internet, by 2022 Steam|Mechanical production equipment 17th Century 1 Division of labour | Electricity | Mass production 18th Century 2 Electronics | IT | automated production 1960 onwards 3 Systems 2015+ 4 Source: WEF 2016
  3. 3. Latest trends- Clinical trials industry Cloud ComputingWearables Artificial Intelligence
  4. 4. Wearables tech to reach $75B by 2025 ~IDTechEx (source) Benefits 1. Billions of people are carrying their own personal devices 2. Mobility, sleep, heart rate count (otherwise unavailable) easily captured 3. Wearables data offers better insights when activity and sleep data are correlated with other collected data -- inside and outside of office visits 4. Wearables data is a useful indicator of behavioral health | Can provide researchers with more objective means to understand how a participant may be feeling while taking a drug Research Kit is an open source framework introduced by Apple that allows researchers and developers to create powerful apps for medical research  The university of Pennsylvania was struggling for over 3 years to recruit enough patients for a study on breast cancer. Over 3 years researches mailed 60K letters and recruited only 351 patients. The team then released an APP called “share the journey”. In less than month 2000 patients had enrolled the program. Case Study - Apple Kit Trend #1- Wearable Electronics (Wearables) How patients will become active participants in the clinical trial
  5. 5. Trend #2- Artificial Intelligence The future is here! Stanford University has created a bioinformatic map of common diseases, using computers to access massive volumes of raw data from various sources, and analyze the same to flag recurring phenotypes and other patterns. “If Tesla cars can drive themselves on the roads and park themselves in the garage, then the day when a fully connected clinical trial platform that can effectively manage all aspects of clinical trials is not far.” AI market to reach $16B by 2022 as per ‘research and markets’. Start-ups like AiCure are developing medication adherence tools that harness AI facial recognition to confirm whether patients have taken the correct medication 1. Active patient participation in clinical trials 2. Creation of consistent standards for clinical trials 3. Precision medicine through artificial intelligence Benefits Case Study
  6. 6. Trend #3- Cloud computing A new paradigm of competitive advantage! Lets go back to the 19th Century and think how electricity become a service from a commodity Data generated by pharma industry doubles every 6 months | By 2020 70% of trials will be outsourced to CROs 1. Your data is not safe on cloud, is a myth! 2. Easy and convenient deployment and management | No programing required 3. Lower cost of operations 4. Easier way to scale and ensure availability and performance 5. Overall ease of use Benefits Acceliant on Azure for “Lupin” Case Study
  7. 7. About Us
  8. 8. Our Story CROs Medical Devices Pharma’s Smarter Solutions We provide faster and smarter eClinical solutions to Pharma's, CROs and Medical devices companies to help them improve their efficiency and monetize cost Global footprint - India, US and UAE Document Management Acceliant's built-in document management function allows study designers to increase trial flexibility Fastest, Smartest, Real-time Comprehensive EDC Acceliant team recognizes the need for a comprehensive EDC system that stays current with technology and users need Unified Trial Builder Utilizing the UTB, development of case report forms for all platforms supported by Acceliant is quick & efficient E- Patient Reported Outcomes Acceliant team help companies electronically collect data directly from the patient, caregiver, and/or clinician Latest Features:-  Randomization  Multi Trial Management  Mobile App  SDTM Current Version: v7.0.2
  9. 9. What makes us your preferred choice Acceliant is Rated Highest in ‘Overall Satisfaction’ in EDC Service Provider Performance “EDC and eCOA / ePRO Market Dynamics and Service Provider Performance (2015)” 1) 21 CFR Part 11 Compliant 2) Awarded with top 10 eClinical Trial Management Solution provider- 2017 3) Awarded with WHO drug medical coding certification 4) Rated highest in “Overall Satisfaction” in EDC service provider performance survey We are on Azure Cloud Hosting partner
  10. 10. Our key product differentiator Integrated eClinical Suite covering CRF, Data Management, Patient Reported Outcomes and Trial Management | Conforms to 21 CFR Part 11 standards Reduce CRF building time to days from months with Unified Trial Builder (UTB) using a simple drag and drop interface Installation, implementation and training in < 2 weeks | Helps in lowering per page or trial cost significantly Multi-lingual capabilities help in global trials Mobile-enabled ePRO patient portal ensures rich trial participation experience for patients Numerous submissions to global regulatory authorities Trial development and deployment time reduced to days from months Time Active and 8supporting from local Phase 1 to global large PMS studies Scalability Ranked Highest in overall satisfaction by global users Usability 100% on Cloud On Cloud
  11. 11. Thank You! 11

×